Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion. 2003

Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
Product Development Laboratories, Sankyo Co. Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan. watatm@shina.sankyo.co.jp

States of interaction between indomethacin (IM) and polyvinylpyrrolidone (PVP) in an amorphous solid dispersion prepared by co-grinding were compared with those between IM and silica nanoparticles. Changes in the carbon chemical states of the solid dispersions were evaluated based on the chemical shift in the 13C-CP/MAS-NMR. Hydrogen bonds between the amide carbonyl of PVP particles and the carboxyl groups of IM molecules were formed by co-grinding. Despite the wide difference in carrier properties, the apparent equilibrium solubility (AES) of IM in the ground IM-PVP mixture was predicted by solid state NMR on the basis of the relationship previously established for IM with SiO(2). This indicates that AES is affected solely by the state of IM, irrespective of the carrier species, and despite carrier-dependent chemical interactions.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011205 Povidone A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. Polvidone,Polyvidon,Polyvinylpyrrolidone,Arufil,Bolinan,Bolinan 40,Crospovidone,Dulcilarmes,Duratears Free,Enterodes,Enterodez,Hypotears,Kollidon,Lacophtal,Lacri-Stulln,Lagrifilm,Liquifilm Lagrimas,Nutrivisc,Oculotect,PVP 40,Periston,Plasdone,Polyplasdone XL,Povidone, Unspecified,Protagens,Protagent,Unifluid,Vidirakt S mit PVP,Vidisic PVP Ophtiole,Wet-Comod,Dulcilarme,Enterode,Hypotear,Polyvidons,Protagen,Unspecified Povidone
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D012822 Silicon Dioxide Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. Silica,Aerosil,Aerosil 380,Cristobalite,Quso G-32,Quso G32,Tridymite,380, Aerosil,Dioxide, Silicon,G32, Quso,Quso G 32

Related Publications

Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
September 1987, Journal of pharmaceutical sciences,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
January 2010, International journal of pharmaceutics,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
May 2005, Chemical & pharmaceutical bulletin,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
October 1997, Chemical & pharmaceutical bulletin,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
May 2020, Pharmaceutics,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
July 2003, Yi chuan xue bao = Acta genetica Sinica,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
January 2023, Current drug delivery,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
January 2021, Advances in experimental medicine and biology,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
April 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Tomoyuki Watanabe, and Susumu Hasegawa, and Naoki Wakiyama, and Akira Kusai, and Mamoru Senna
December 2020, Journal of pharmaceutical sciences,
Copied contents to your clipboard!